×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Qualification and Oversight in Decentralized Trials: Practical Considerations for Clinical Operations and Quality Oversight
Session Chair(s)
Dennis Salotti, MBA, MS
Senior Director and Head of Strategic Outsourcing and Clinical Innovation
Jazz Pharmaceuticals , United States
In this interactive panel discussion, we will explore the critical role that providers, sponsors, and collaboratives play in driving greater adoption of decentralized clinical trials (DTs). Attendees are encouraged to engage in the discussion.
Learning Objective : Define familiarity with the use of technologies and approaches enabling DTs; Identify challenges of vendor qualification for DTs versus traditional trials; Describe key risks when qualifying DT service providers; Characterize change management elements of success and how providers can support this effort; Describe role collaboratives and standards play in facilitating broader adoption of DTs.
Speaker(s)
Panelist
Alison Holland
Medable, United States
Executive General Manager, Digital and Decentralized Solutions
Qualification and Oversight in Decentralized Trials: Practical Considerations for Clinical Operations and Quality Oversight
Heather Zigmund, PharmD
AstraZeneca, United States
Senior Director, Global Head of Study Management Early Stage Development BioPhar
Have an account?